Development of an in vivo rat screen model to predict pharmacokinetic interactions of CYP3A4 substrates

By Mandlekar S. V.   Rose A. V.   Cornelius G.   Sleczka B.   Caporuscio C.   Wang J.   Marathe P. H.  

Xenobiotica, Vol. 37, Iss. 9, 2007-09 ,pp. : 923-942

Informa Healthcare

Access to resources Recommend Favorite

Prediction of clinical CYP3A4 induction using cryopreserved human hepatocytes

By Kaneko A.   Kato M.   Endo C.   Nakano K.   Ishigai M.   Takeda K.  

Xenobiotica, Vol. 40, Iss. 12, 2010-12 ,pp. : 791-799

Informa Healthcare

Access to resources Recommend Favorite

A new methodology for predicting human pharmacokinetics for inhaled drugs from oratracheal pharmacokinetic data in rats

By Jones Rhys M.   Harrison Anthony  

Xenobiotica, Vol. 42, Iss. 1, 2012-01 ,pp. : 75-85

Informa Healthcare

Access to resources Recommend Favorite

Human CYP3A4-introduced HepG2 cells: In vitro screening system of new chemicals for the evaluation of CYP3A4-inhibiting activity

By Araki N.   Tsuruoka S.   Wang N.   Hasegawa G.   Yanagihara H.   Ando H.   Omasa T.   Enosawa S.   Nagai H.   Fujimura A.  

Xenobiotica, Vol. 38, Iss. 11, 2008-11 ,pp. : 1355-1364

Informa Healthcare

Access to resources Recommend Favorite

Prediction of in vivo hepatic clearance from in vitro data using cryopreserved human hepatocytes

By Bachmann K.   Byers J.   Ghosh R.  

Xenobiotica, Vol. 33, Iss. 5, 2003-01 ,pp. : 475-483

Informa Healthcare

Access to resources Recommend Favorite